- Report
- October 2024
- 189 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- November 2024
- 150 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- March 2025
- 252 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- August 2024
- 175 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- June 2020
Global
From €5679EUR$5,950USD£4,758GBP
From €3340EUR$3,500USD£2,799GBP
- Report
- November 2023
- 178 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- August 2022
- 112 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- January 2024
- 148 Pages
Global
From €4056EUR$4,250USD£3,398GBP
-
Journal - March 2025
Global
From €406EUR$425USD£340GBP
- Report
- October 2024
- 70 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- January 2025
- 132 Pages
Global
From €907EUR$950USD£760GBP
-
Journal - March 2025
- 58 Pages
Global
From €406EUR$425USD£340GBP
- Report
- November 2021
- 365 Pages
Global
From €3340EUR$3,500USD£2,799GBP
- Book
- October 2018
- 668 Pages

Animal biotechnology is a branch of biotechnology that focuses on the application of genetic engineering and other molecular biology techniques to animals. It is used to modify the genetic makeup of animals to produce desired traits, such as disease resistance, improved growth, and improved production of food and other products. Animal biotechnology is used in a variety of industries, including agriculture, pharmaceuticals, and veterinary medicine.
Animal biotechnology is used to develop new animal models for research, to improve animal health and welfare, and to produce new animal-derived products. It is also used to develop new animal-derived pharmaceuticals, such as vaccines and antibodies, and to produce transgenic animals for use in biomedical research.
Animal biotechnology is a rapidly growing field, with many companies investing in research and development. Examples of companies in the animal biotechnology market include Genus plc, Recombinetics, Inc., and Genocea Biosciences, Inc. Show Less Read more